CEPHAZOLIN VIATRIS cefazolin 2g powder for solution for injection vial

Ország: Ausztrália

Nyelv: angol

Forrás: Department of Health (Therapeutic Goods Administration)

Vedd Meg Most

Aktív összetevők:

cefazolin sodium, Quantity: 2198 mg

Beszerezhető a:

Alphapharm Pty Ltd

INN (nemzetközi neve):

cefazolin sodium

Gyógyszerészeti forma:

Injection, powder for

Összetétel:

Excipient Ingredients:

Az alkalmazás módja:

Intramuscular, Intravenous, Intravenous Infusion

db csomag:

10 vials, 1 vial

Recept típusa:

(S4) Prescription Only Medicine

Terápiás javallatok:

Treatment of the following serious infections due to susceptible organisms.. Respiratory tract infections due to Strep. pneumoniae, Klebsiella sp., H. influenzae, Staph. aureus (penicillin sensitive and penicillin resistant) and group A beta-haemolytic Streptococci. Injectable benzathine penicillin is considered to be the drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cephazolin is effective in the eradication of Streptococci from the nasopharynx; however, data establishing the efficacy of cephazolin in the subsequent prevention of rheumatic fever are not available at present.. Genitourinary tract infections due to E. coli, P. mirabilis, Klebsiella sp. and some strains of Enterobacter and enterococci.. Skin and skin structure infections due to Staph. aureus (penicillin sensitive and penicillin resistant) and group A beta-haemolytic Streptococci and other strains of Streptococci.. Bone and joint infections due to Staph. aureus.. Septicaemia due to Strep. pneumoniae, Staph. aureus (penicillin sensitive and penicillin resistant), P. mirabilis, E. coli and Klebsiella sp.. Endocarditis due to Staph. aureus (penicillin sensitive and penicillin resistant) and group A beta-haemolytic Streptococci.. Appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cephazolin.

Termék összefoglaló:

Visual Identification: White to off white crystalline powder.; Container Type: Vial; Container Material: Glass Type III Clear; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Engedélyezési státusz:

Licence status A

Engedély dátuma:

2010-04-09

Betegtájékoztató

                                CEPHAZOLIN
ALPHAPHARM
_contains the active ingredient cephazolin sodium_
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about Cephazolin
Alphapharm.
It does not contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
All medicines have risks and
benefits. Your doctor has weighed
the risks of you using Cephazolin
Alphapharm against the benefits they
expect it will have for you.
IF YOU HAVE ANY CONCERNS ABOUT
USING THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT CEPHAZOLIN
ALPHAPHARM IS USED
FOR
The name of your medicine is
Cephazolin Alphapharm. It contains
the active ingredient cephazolin
sodium.
Cephazolin Alphapharm is an
antibiotic used to treat infections in
different parts of the body caused by
bacteria.
Cephazolin Alphapharm belongs to a
group of antibiotics called
cephalosporins. These antibiotics
work by killing the bacteria that are
causing your infection.
Your doctor may have prescribed
Cephazolin Alphapharm for another
reason.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY CEPHAZOLIN
ALPHAPHARM HAS BEEN PRESCRIBED
FOR YOU.
Cephazolin Alphapharm is available
only with a doctor's prescription. It is
not addictive.
BEFORE YOU ARE GIVEN
CEPHAZOLIN
ALPHAPHARM
_WHEN YOU MUST NOT BE GIVEN_
_CEPHAZOLIN ALPHAPHARM_
DO NOT USE CEPHAZOLIN
ALPHAPHARM IF:
1.
YOU HAVE AN ALLERGY TO THE
ACTIVE INGREDIENT, CEPHAZOLIN
SODIUM, OR TO ANY OTHER
CEPHALOSPORINS
Some of the symptoms of an allergic
reaction may include asthma,
wheezing, shortness of breath,
swelling of the face, lips or tongue
which may cause difficult in
swallowing or breathing, skin rash,
itching or hives.
2. YOU HAVE HAD A SERIOUS ALLERGIC
REACTION TO ANY PENICILLINS.
You may be more likely to have an
allergic reaction to Cephazolin
Alphapharm if you are allergic to
penicillin medicines.
DO NOT USE CEPHAZOLIN
ALPHAPHARM IF THE PACKAGING IS
TORN OR SHOWS SIGNS OF TAMPERING.
DO NOT US
                                
                                Olvassa el a teljes dokumentumot
                                
                            

Termékjellemzők

                                AUSTRALIAN PRODUCT INFORMATION
CEPHAZOLIN ALPHAPHARM
_Cefazolin sodium _
1
NAME OF THE MEDICINE
Cefazolin sodium
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each vial of
Cephazolin Alphapharm 1 g powder for injection contains 1 gram of
cefazolin (as sodium) as
the active ingredient.
Each vial of
Cephazolin Alphapharm 2 g powder for injection contains 2 grams of
cefazolin (as sodium) as
the active ingredient.
3
PHARMACEUTICAL FORM
Cephazolin Alphapharm is supplied as a white to off white crystalline
powder.
Cephazolin Alphapharm 1 g powder for injection is presented in a clear
glass vial and must be reconstituted
prior to use.
Cephazolin Alphapharm 2 g powder for injection is presented in a clear
glass vial and must be reconstituted
prior to use.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Treatment of the following serious infections due to susceptible
organisms.
Respiratory tract infections due to Strep. pneumoniae, Klebsiella sp.,
H. influenzae, Staph. aureus (penicillin
sensitive and penicillin resistant) and group A beta-haemolytic
Streptococci. Injectable benzathine penicillin
is considered to be the drug of choice in the treatment and prevention
of streptococcal infections, including
the prophylaxis of rheumatic fever. Cefazolin is effective in the
eradication of Streptococci from the
nasopharynx; however, data establishing the efficacy of cefazolin in
the subsequent prevention of rheumatic
fever are not available at present.
Genitourinary tract infections due to E. coli, P. mirabilis,
Klebsiella sp. and some strains of Enterobacter and
enterococci.
Skin and skin structure infections due to Staph. aureus (penicillin
sensitive and penicillin resistant) and group
A beta-haemolytic Streptococci and other strains of Streptococci.
Bone and joint infections due to Staph. aureus.
Septicaemia due to Strep. pneumoniae, Staph. aureus (penicillin
sensitive and penicillin resistant), P.
mirabilis, E. coli and Klebsiella sp.
Endocarditis due to Staph. aureus (penicillin sensitive and penicillin
resistant) and grou
                                
                                Olvassa el a teljes dokumentumot